Cost description of chemotherapy regimens for the treatment of metastatic pancreas cancer
出版年份 2016 全文链接
标题
Cost description of chemotherapy regimens for the treatment of metastatic pancreas cancer
作者
关键词
Metastatic pancreas cancer, Chemotherapy costs, Value, Toxicity costs, First-line regimens
出版物
MEDICAL ONCOLOGY
Volume 33, Issue 5, Pages -
出版商
Springer Nature
发表日期
2016-04-14
DOI
10.1007/s12032-016-0762-8
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
- (2015) N. I. Cherny et al. ANNALS OF ONCOLOGY
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Can Money Really Be No Object When Cancer Care Is the Subject?
- (2015) Leonard B. Saltz JOURNAL OF CLINICAL ONCOLOGY
- First- and Second-Line Bevacizumab in Addition to Chemotherapy for Metastatic Colorectal Cancer: A United States–Based Cost-Effectiveness Analysis
- (2015) Daniel A. Goldstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance)
- (2015) Hope S. Rugo et al. JOURNAL OF CLINICAL ONCOLOGY
- Modified gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer (MPC): A single-institution experience.
- (2015) Kavya Krishna et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
- (2015) Lowell E. Schnipper et al. JOURNAL OF CLINICAL ONCOLOGY
- Cost-effectiveness of FOLFIRINOX for first-line treatment of metastatic pancreatic cancer
- (2014) C.L. Attard et al. Current Oncology
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Projections of the Cost of Cancer Care in the United States: 2010-2020
- (2011) A. B. Mariotto et al. JNCI-Journal of the National Cancer Institute
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- A prospective study of chemotherapy-induced febrile neutropenia in the South West London Cancer Network. Interpretation of study results in light of NCAG/NCEPOD findings
- (2010) M Okera et al. BRITISH JOURNAL OF CANCER
- Transferability of Economic Evaluations Across Jurisdictions: ISPOR Good Research Practices Task Force Report
- (2009) Michael Drummond et al. VALUE IN HEALTH
- An Empiric Estimate of the Value of Life: Updating the Renal Dialysis Cost-Effectiveness Standard
- (2008) Chris P. Lee et al. VALUE IN HEALTH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now